Short-term Effects of Tai Chi Chuan Exercise on the Regulation of Lipid and Glucose Metabolisms and Endothelial Function

April 11, 2018 updated by: Cheng-Deng Kuo, Changhua Christian Hospital

The Effect of Tai Chi Chuan on the Endothelin, Insulin, Blood Lipid, Blood Sugar, Aldosterone and Hemodynamics in the Elderly Adults

The short term effects of TCC exercise are the significant increase in serum insulin and insulin resistance, and the significant decrease in serum TC, HDL-C, ET-1 and insulin sensitivity in TCC practitioners. TCC might be benefit the health of its practitioners through the regulation of lipid and glucose metabolism and endothelial function.

Study Overview

Detailed Description

Tai Chi Chuan (TCC) has been shown to be beneficial to the health. However, its effects on lipid and glucose metabolism are not fully understood. This study investigated the short term effect of TCC exercise on lipid and glucose metabolism and endothelial function in TCC practitioners. Twenty-one TCC practitioners and nineteen normal controls were included in this study. The hemodynamics, serum insulin, indices of insulin resistance/sensitivity, serum endothelin-1 (ET-1), blood lipids and aldosterone before and 30 min after a rest or a session of classical Yang's TCC exercise were compared.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ilan, Taiwan
        • Wan-An Lu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • TCC practitioners in a TCC training center in Taiwan over 50 years of age
  • Healthy subjects without TCC experience over 50 years of age

Exclusion Criteria:

  • Subjects who had major cardiopulmonary disease
  • Subjects who have diabetes mellitus, renal or liver disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TCC group
Classical Yang's TCC exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in quantitative insulin sensitivity check index
Time Frame: before and 30 minutes after the completion of TCC exercise
change in insulin sensitivity due to TCC
before and 30 minutes after the completion of TCC exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in serum total cholesterol
Time Frame: before and 30 minutes after the completion of TCC exercise
change in serum total cholesterol due to TCC
before and 30 minutes after the completion of TCC exercise
change in homeostasis model assessment-estimated insulin resistance
Time Frame: before and 30 minutes after the completion of TCC exercise
change in insulin resistance by TCC
before and 30 minutes after the completion of TCC exercise

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in serum triglyceride
Time Frame: before and 30 minutes after the completion of TCC exercise
change in serum level of triglyceride due to TCC
before and 30 minutes after the completion of TCC exercise
change in serum low density lipoprotein
Time Frame: before and 30 minutes after the completion of TCC exercise
change in serum level of low density lipoprotein due to TCC
before and 30 minutes after the completion of TCC exercise
change in serum high density lipoprotein
Time Frame: before and 30 minutes after the completion of TCC exercise
change in serum level of high density lipoprotein due to TCC
before and 30 minutes after the completion of TCC exercise
change in serum insulin
Time Frame: before and 30 minutes after the completion of TCC exercise
change in serum level of insulin due to TCC
before and 30 minutes after the completion of TCC exercise
change in serum endothelin-1
Time Frame: before and 30 minutes after the completion of TCC exercise
change in serum level of endothelin-1 due to TCC
before and 30 minutes after the completion of TCC exercise
change in serum aldosterone
Time Frame: before and 30 minutes after the completion of TCC exercise
change in serum level of aldosterone due to TCC
before and 30 minutes after the completion of TCC exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cheng-Deng Kuo, MD,PhD, Changhua Christian Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2009

Primary Completion (Actual)

November 30, 2009

Study Completion (Actual)

December 31, 2009

Study Registration Dates

First Submitted

March 30, 2018

First Submitted That Met QC Criteria

April 11, 2018

First Posted (Actual)

April 19, 2018

Study Record Updates

Last Update Posted (Actual)

April 19, 2018

Last Update Submitted That Met QC Criteria

April 11, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • V98E2-014

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) are available after the manuscript has been accepted for publication

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physiological Effect of TCC on Glucose Metabolism

Clinical Trials on Classical Yang's TCC exercise

3
Subscribe